FSIRX | HBLCX | FSIRX / HBLCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 18 years | - |
Gain YTD | 6.190 | 7.929 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2000 | - |
Min. Initial Investment IRA | 500 | 2000 | 25% |
Net Assets | 496M | 12.8B | 4% |
Annual Yield % from dividends | 5.18 | 2.65 | 196% |
Returns for 1 year | 7.99 | 13.88 | 58% |
Returns for 3 years | 11.09 | -1.97 | -562% |
Returns for 5 years | 30.67 | 13.19 | 233% |
Returns for 10 years | 33.35 | 29.45 | 113% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 28.61 | 0.22 | +0.76% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
SDVY | 35.72 | 0.06 | +0.17% |
First Trust SMID Cp Rising Div Achv ETF | |||
GSST | 50.56 | 0.01 | +0.02% |
Goldman Sachs Access Ultra Short Bd ETF | |||
UFEB | 32.31 | -0.01 | -0.02% |
Innovator US Equity Ultra Bffr ETF™ Feb | |||
ENFR | 28.23 | -0.09 | -0.32% |
Alerian Energy Infrastructure ETF |